Medgenics Inc (NASDAQ:GNMX) was downgraded by equities researchers at ValuEngine from a “sell” rating to a “strong sell” rating in a report issued on Friday. Other research analysts have also issued research reports about the stock. Jefferies Group LLC restated a “hold” rating and set a $1.50 target price on shares of Medgenics in a […]
